Evidence map›Paper›PMID 35455725›Full record

ArticleJournal of personalized medicine2022

Efficacy of Telemedicine and At-Home Telemonitoring following Hospital Discharge in Patients with COVID-19.

Roi Suárez-Gil, Emilio Casariego-Vales, Rosa Blanco-López, Fernando Santos-Guerra, Cristina Pedrosa-Fraga, Álvaro Fernández-Rial, Iria Íñiguez-Vázquez, María Mar Abad-García, Mercedes Bal-Alvaredo, On Behalf Of The Members Of The Lugo Telea-Covid Team

Abstract read
In one paragraph

Article in Journal of personalized medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Hospitalisation at Home of Patients with COVID-19: A Qualitative Study of User Experiences.International journal of environmental research and public health · 2023
    Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Roi Suárez-GilInternal Medicine Department, Lucus Augusti University Hospital, 27003 Lugo, Spain.
Emilio Casariego-ValesInternal Medicine Department, Lucus Augusti University Hospital, 27003 Lugo, Spain.ORCID 0000-0001-5033-1906
Rosa Blanco-LópezDay Hospital Nursing, Lucus Augusti University Hospital, 27003 Lugo, Spain.
Fernando Santos-GuerraInformation Systems Project Management Department, Galician Health Service, Regional Ministry of Health, 15703 Santiago de Compostela, Spain.
Cristina Pedrosa-FragaInternal Medicine Department, Lucus Augusti University Hospital, 27003 Lugo, Spain.
Álvaro Fernández-RialInternal Medicine Department, Lucus Augusti University Hospital, 27003 Lugo, Spain.
Iria Íñiguez-VázquezInternal Medicine Department, Lucus Augusti University Hospital, 27003 Lugo, Spain.
María Mar Abad-GarcíaDay Hospital Nursing, Lucus Augusti University Hospital, 27003 Lugo, Spain.
Mercedes Bal-AlvaredoInternal Medicine Department, Lucus Augusti University Hospital, 27003 Lugo, Spain.
On Behalf Of The Members Of The Lugo Telea-Covid Team

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Aim: This work aims to evaluate the safety and utility of an at-home telemedicine with telemonitoring program for discharged COVID-19 patients. Methods: This is a retrospective cohort study of all patients discharged home in Galicia between 6 March 2020 and 15 February 2021. We evaluated a structured, proactive monitoring program conducted by the ASLAM (Área Sanitaria de Lugo, A Mariña y Monforte de Lemos) Healthcare Area team compared to patients discharged in the rest of the Autonomous Community of Galicia. Results: During the study period, 10,517 patients were hospitalized for COVID-19 and 8601 (81.8%) were discharged. Of them, 738 (8.6%) were discharged in ASLAM and 7863 (91.4%) were discharged in the rest of Galicia. Of those discharged in ASLAM, 475 (64.4%) patients were monitored. Compared to patients in the rest of Galicia, the group monitored via telemedicine had a significantly shorter first hospital stay (p < 0.0001), a lower readmission rate (p = 0.05), and a shorter second hospital stay (p = 0.04), with no differences in emergency department visits or 90-day all-cause mortality. Conclusion: A structured, proactive telemedicine with telemonitoring program for discharged COVID-19 patients is a safe, useful tool that reduces the mean length of hospital stay and readmissions.

Indexed as

COVID-19hospital dischargetelemedicine

Identifiers

PMID35455725
PMCPMC9029667

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.